Nombre del producto:4,4,5,5-Tetramethyl-2-(4-(2-(trifluoromethyl)oxetan-2-yl)phenyl)-1,3,2-dioxaborolane

IUPAC Name:4,4,5,5-tetramethyl-2-{4-[2-(trifluoromethyl)oxetan-2-yl]phenyl}-1,3,2-dioxaborolane

CAS:2133473-11-5
Fórmula molecular:C16H20BF3O3
Pureza:95%+
Número de catálogo:CM1050037
Peso molecular:328.14

Unidad de embalaje Stock disponible Precio($) Cantidad
CM1050037-250mg in stock ʼnƓŗ
CM1050037-500mg in stock ƥƥŹǵ
CM1050037-1g in stock ƥůŗŗ
CM1050037-5g in stock ůŗǤʼn

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :2133473-11-5
Fórmula molecular:C16H20BF3O3
Punto de fusión:-
Código de sonrisas:CC1(C)C(C)(C)OB(O1)C2=CC=C(C=C2)C3(OCC3)C(F)(F)F
Densidad:
Número de catálogo:CM1050037
Peso molecular:328.14
Punto de ebullición:
Nº Mdl:
Almacenamiento:

Category Infos

Oxetanes
Oxygen heterocycles are one of the most common heterocycles in drugs and natural products. Oxetene has high polarity and is also a good acceptor for hydrogen bond, which contributes to the metabolism and chemical stability of its host molecules. When substituted for commonly used functional groups such as gem dimethyl or carbonyl, oxetane units can induce profound changes in water solubility, lipophilicity, metabolic stability and conformational preference. Four of the FDA-approved drugs contain oxetenes: Orlistat, Paclitaxel, and two of its derivatives, Docetaxel and Cabazitaxel. Currently, oxetane-containing building blocks are flourishing in medicinal chemistry and drug discovery.